Comparing the Efficacy of Nitazoxanide Versus Rifaximin in Adult Patients With Irritable Bowel Syndrome Without Constipation

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
This study aim to compare the efficacy of nitazoxanide in 2-week course of treatment with rifaximin in treating diarrhea associated with IBS. We also aim to study its effect over 10 weeks after treatment to evaluate its efficacy in eradicating symptoms of IBS in the long run.
Epistemonikos ID: 7819cc9aed3e911c32558b67adc77cc89f20e57f
First added on: May 13, 2024